Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates

NCT00066989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infections

Interventions

DRUG: Staphylococcus aureus Immune Globulin (Human) 5%

Sponsor

Nabi Biopharmaceuticals